Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Kexing Biopharm (688136)
- 24.51
- -0.56-2.23%
Market Closed May 6 15:00 CST
4.93BMarket Cap44.00P/E (TTM)
25.11High24.20Low5.79MlotVolume25.01Open25.07Prev Close141.86MTurnover2.88%Turnover Ratio31.71P/E (Static)201.26MShares63.9152wk High2.85P/B4.93BFloat Cap24.0752wk Low30.08Limit Up201.26MShs Float63.91Historical High20.06Limit Down3.63%Range %10.53Historical Low0.08Dividend TTM24.51Avg Price2.94MlotAsk0.33%Div Yield TTM1Lot Size2.51MlotBid
Kexing Biopharm (688136) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 25.05%614.04M | 17.29%650.43M | 61.03%492.69M | 1.83%447.8M | 38.79%491.04M | -2.50%554.56M | -7.46%305.96M | -18.79%439.76M | -26.86%353.79M | -27.58%568.8M |
| Transactional financial assets | -83.57%14M | ---- | -25.97%120.11M | 133.74%173.18M | -54.78%85.24M | ---- | -42.46%162.25M | -56.05%74.09M | -27.56%188.5M | ---- |
| Notes receivable and accounts receivable | 18.82%642M | 27.61%638.76M | 56.92%672.49M | 30.43%570.54M | 52.74%540.31M | 75.19%500.56M | 17.53%428.55M | 18.96%437.43M | -2.01%353.75M | -20.84%285.72M |
| -Notes receivable | 141.28%54.21M | 133.19%58.97M | 45.21%32.7M | 57.28%32.7M | 90.11%22.47M | 125.86%25.29M | -40.70%22.52M | -51.36%20.79M | -52.08%11.82M | -52.49%11.2M |
| -Accounts receivable | 13.51%587.79M | 21.99%579.78M | 57.57%639.8M | 29.09%537.84M | 51.45%517.84M | 73.13%475.28M | 24.30%406.03M | 28.22%416.64M | 1.66%341.93M | -18.63%274.52M |
| Other receivables (including interest and dividends) | 20.20%20.69M | 26.54%20.12M | 15.08%18.55M | 212.12%17.6M | 259.61%17.21M | 257.34%15.9M | 251.59%16.12M | 31.21%5.64M | 28.75%4.79M | 36.97%4.45M |
| -Other receivable | ---- | 26.54%20.12M | ---- | 212.12%17.6M | ---- | 257.34%15.9M | ---- | 31.21%5.64M | ---- | 36.97%4.45M |
| Advance payment | 663.70%67.35M | 594.81%46.62M | 48.25%19.89M | -31.55%12.35M | -72.93%8.82M | -73.08%6.71M | -32.37%13.42M | 7.19%18.04M | 25.11%32.58M | 16.70%24.93M |
| Inventories | 23.09%155.36M | -1.83%139.22M | -11.92%124.74M | -17.30%128.9M | -29.22%126.21M | -25.90%141.81M | -16.82%141.62M | -11.10%155.87M | -12.48%178.31M | -8.08%191.36M |
| Receivable financing | -66.38%16.84M | 39.99%88.55M | 88.90%96.19M | -6.67%73.46M | 6.27%50.11M | 12.30%63.25M | 13.76%50.92M | 110.09%78.71M | 137.55%47.15M | 144.20%56.32M |
| Other current assets | 358.06%22.92M | 372.44%23.66M | 27.23%5.42M | 324.76%8.37M | 165.35%5M | 144.78%5.01M | 121.44%4.26M | -39.07%1.97M | -81.52%1.89M | -64.09%2.05M |
| Total current assets | 17.32%1.55B | 24.81%1.61B | 38.02%1.55B | 18.22%1.43B | 14.06%1.32B | 13.60%1.29B | -7.93%1.12B | -8.02%1.21B | -15.37%1.16B | -19.68%1.13B |
| Non Current assets | ||||||||||
| Other equity investment | -0.19%15.83M | -0.19%15.83M | 5.73%15.86M | 5.73%15.86M | 5.73%15.86M | 5.73%15.86M | 0.00%15M | 0.00%15M | 0.00%15M | 0.00%15M |
| Other non-current financial assets | 28.15%289.13M | 58.95%291.85M | 8.85%231.16M | 13.51%241.05M | -0.30%225.61M | -18.86%183.61M | -14.72%212.36M | -19.27%212.36M | -6.53%226.3M | -6.53%226.3M |
| Investment real estate | -6.36%18.99M | -6.26%19.32M | -6.01%19.64M | -6.15%19.97M | -6.06%20.28M | -6.05%20.61M | -6.11%20.9M | -5.79%21.28M | -5.79%21.59M | -5.63%21.93M |
| Fixed assets | ---- | 0.84%983.09M | ---- | -0.38%1.01B | ---- | 21.15%974.87M | ---- | 31.47%1.01B | ---- | 6.08%804.69M |
| Constru in process | ---- | -37.45%110.61M | ---- | -33.18%113.23M | ---- | -52.54%176.82M | ---- | -54.95%169.44M | ---- | 45.21%372.56M |
| Intangible assets | 1.39%222.67M | 1.93%229.48M | 28.42%235.99M | 42.79%223.66M | 41.54%219.61M | 41.84%225.14M | 13.47%183.76M | -3.62%156.64M | -4.08%155.16M | -4.28%158.72M |
| Development expenditure | 178.65%99.2M | 167.95%82.74M | 193.41%64.38M | 526.80%45.19M | --35.6M | --30.88M | -81.42%21.94M | -89.76%7.21M | ---- | ---- |
| Long deferred expense | -26.16%13.38M | -25.63%14.49M | -23.77%15.74M | -25.06%16.62M | 1,157.69%18.12M | 533.19%19.49M | 249.84%20.65M | 155.59%22.17M | -87.03%1.44M | -77.98%3.08M |
| Deferred tax assets | 14.56%129.06M | 2.98%120.71M | 3.91%116.71M | 3.40%120.36M | -14.28%112.66M | -12.51%117.22M | 27.23%112.32M | 26.10%116.4M | 92.29%131.43M | 100.40%133.98M |
| Usufruct assets | -19.67%18M | -78.84%5.41M | -72.03%8.05M | -36.33%20.34M | -36.21%22.4M | 13.65%25.58M | 2.08%28.76M | 0.96%31.94M | 4.25%35.12M | -39.83%22.51M |
| Other non current assets | -12.71%50.95M | -39.35%48.77M | -53.41%42.47M | -50.85%59.07M | -53.71%58.37M | -40.29%80.42M | -17.12%91.16M | 17.36%120.19M | -26.32%126.1M | -22.40%134.68M |
| Total non current assets | 3.61%1.94B | 2.76%1.93B | -0.84%1.86B | -0.06%1.89B | -1.75%1.87B | -1.21%1.87B | -4.09%1.88B | -1.37%1.89B | 8.99%1.9B | 8.22%1.9B |
| Total assets | 9.29%3.49B | 11.74%3.53B | 13.70%3.41B | 7.08%3.32B | 4.24%3.19B | 4.33%3.16B | -5.56%3B | -4.08%3.1B | -1.73%3.06B | -4.22%3.03B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -33.90%176.61M | -39.50%162.83M | 21.38%267.48M | 113.35%285.85M | 121.11%267.19M | 122.96%269.12M | 53.01%220.37M | -20.26%133.98M | -4.39%120.84M | -25.81%120.7M |
| Notes payable and accounts payable | 8.47%195.35M | 12.22%229.18M | 29.13%201.38M | 0.31%182.96M | 4.72%180.09M | 5.56%204.23M | -22.10%155.95M | 6.28%182.4M | 22.85%171.98M | -10.93%193.46M |
| -Notes payable | --6.02M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Accounts payable | 5.13%189.33M | 12.22%229.18M | 29.13%201.38M | 0.31%182.96M | 4.72%180.09M | 5.56%204.23M | -22.10%155.95M | 6.28%182.4M | 22.85%171.98M | -10.93%193.46M |
| Contract liabilities | 56.36%16.43M | 40.77%12.92M | 65.37%10.28M | 183.79%13.81M | 50.52%10.51M | -53.24%9.18M | 12.38%6.22M | -46.33%4.87M | 31.89%6.98M | 12.97%19.64M |
| Advance receipts | 0.33%679.66K | 1.48%605.05K | 120.26%1.13M | -5.61%1.06M | 29.92%677.45K | -25.45%596.23K | -11.11%515K | -0.91%1.12M | 838.57%521.43K | 31.26%799.74K |
| Salaries payable | 36.08%35.48M | 20.91%35.7M | 7.58%14.75M | 12.68%15.24M | 13.46%26.07M | 20.01%29.52M | 0.54%13.71M | -17.86%13.53M | -2.67%22.98M | -19.56%24.6M |
| Taxs payable | 77.65%8.9M | 86.90%13.26M | 161.55%11.74M | -20.15%6.86M | 7.62%5.01M | 70.67%7.09M | -55.79%4.49M | -1.81%8.59M | 32.84%4.65M | -58.58%4.16M |
| Other payable (including interest and dividends) | 3.51%28.98M | 10.37%30.36M | 4.54%28.04M | 6.29%28.84M | 37.77%28M | 30.67%27.5M | 47.21%26.82M | 38.52%27.13M | -3.02%20.32M | 1.56%21.05M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --170.72K | ---- | ---- |
| -Other payable | ---- | 10.37%30.36M | ---- | 6.96%28.84M | ---- | 30.67%27.5M | ---- | 37.65%26.96M | ---- | 1.56%21.05M |
| Non current liabilities due within one year | 54.24%540.18M | 54.87%504.41M | 46.29%478.67M | -11.35%367.58M | -16.04%350.22M | 15.61%325.7M | 6.66%327.2M | 226.69%414.63M | 230.89%417.15M | 293.18%281.73M |
| Other current liabilities | 138.32%34.55M | 137.93%32M | 150.41%19.17M | 658.65%11.07M | 1,090.13%14.5M | 248.77%13.45M | 39.53%7.66M | -83.96%1.46M | -68.35%1.22M | -54.56%3.86M |
| Total current liabilities | 17.56%1.04B | 15.21%1.02B | 35.35%1.03B | 15.94%913.27M | 15.08%882.26M | 32.30%886.4M | 8.28%762.94M | 48.44%787.71M | 70.48%766.64M | 24.22%669.99M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | 185.78%20.13M | 154.05%18.99M | -37.22%6.34M | -16.72%8.79M | -46.87%7.04M | -34.17%7.48M | -35.19%10.1M | -35.23%10.56M | 55.40%13.26M | -21.93%11.36M |
| Long term deferred income | 268.06%11.13M | 257.93%11.28M | 42.24%4.28M | -21.29%2.9M | -40.16%3.02M | -40.79%3.15M | 46.67%3.01M | 71.95%3.69M | 124.91%5.06M | 610.27%5.32M |
| Lease liabilities | -34.17%8.27M | -87.72%1.82M | -86.13%2.5M | -43.98%11.74M | -41.74%12.56M | -16.87%14.78M | -11.21%18M | -0.41%20.96M | 1.65%21.55M | -28.75%17.79M |
| Total non current liabilities | 12.60%724.64M | 19.35%759.79M | 7.40%662.55M | 3.06%719.91M | -4.43%643.55M | -12.83%636.59M | -12.50%616.9M | -24.56%698.53M | -22.57%673.36M | -10.88%730.3M |
| Total liabilities | 15.47%1.76B | 16.94%1.78B | 22.85%1.7B | 9.89%1.63B | 5.96%1.53B | 8.76%1.52B | -2.11%1.38B | 2.03%1.49B | 9.15%1.44B | 3.05%1.4B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.81%201.26M | 0.81%201.26M | 1.03%201.26M | 1.03%201.26M | 0.22%199.64M | 0.22%199.64M | 0.00%199.2M | 0.00%199.2M | 0.25%199.2M | 0.25%199.2M |
| Capital reserve funds | 1.59%1.31B | 1.87%1.31B | 2.63%1.32B | 2.84%1.32B | 0.75%1.29B | 0.54%1.29B | 0.27%1.28B | 0.12%1.28B | 0.49%1.28B | 0.58%1.28B |
| Surplus reserve funds | 83.81%45.87M | 83.81%45.87M | 25.71%24.96M | 25.71%24.96M | 25.71%24.96M | 25.71%24.96M | 0.00%19.85M | 0.00%19.85M | 0.00%19.85M | 0.00%19.85M |
| Retained profit | 42.48%252.77M | 78.30%270.7M | 73.40%247.31M | 57.57%216.39M | 28.69%177.41M | 21.03%151.83M | -45.44%142.63M | -48.79%137.33M | -55.09%137.85M | -60.27%125.45M |
| Less:Treasury stock | 176.94%86.18M | 158.23%80.36M | 152.26%78.5M | 152.26%78.5M | 55.62%31.12M | --31.12M | --31.12M | --31.12M | --20M | ---- |
| Other composite income | 7.80%1.2M | -16.23%932.72K | 194.17%1.03M | 220.79%1.09M | 191.66%1.11M | 17,887.10%1.11M | --351.27K | --339.12K | --380.54K | ---6.26K |
| Shareholders equity without minority interests | 3.81%1.73B | 7.10%1.75B | 6.13%1.71B | 4.73%1.68B | 2.73%1.66B | 0.55%1.63B | -8.30%1.62B | -9.06%1.61B | -10.10%1.62B | -10.08%1.63B |
| Minority interests | -75.16%897.35K | -65.09%1.51M | -59.24%2.18M | -53.48%2.96M | -6.41%3.61M | -9.14%4.34M | -13.25%5.34M | -16.49%6.35M | 206.55%3.86M | 288.82%4.77M |
| Total shareholder equity | 3.64%1.73B | 6.91%1.75B | 5.91%1.72B | 4.50%1.69B | 2.71%1.67B | 0.52%1.64B | -8.32%1.62B | -9.10%1.61B | -9.70%1.62B | -9.69%1.63B |
| Total liabilityies and equity | 9.29%3.49B | 11.74%3.53B | 13.70%3.41B | 7.08%3.32B | 4.24%3.19B | 4.33%3.16B | -5.56%3B | -4.08%3.1B | -1.73%3.06B | -4.22%3.03B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm